BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maniar K, Moideen A, Mittal A, Patil A, Chakrabarti A, Banerjee D. A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug? Pharmacol Res 2017;117:103-28. [PMID: 27939359 DOI: 10.1016/j.phrs.2016.12.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Tseng CH. Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus. Biomolecules 2021;11:1405. [PMID: 34680039 DOI: 10.3390/biom11101405] [Reference Citation Analysis]
2 Robertson MD. Prebiotics and type 2 diabetes: targeting the gut microbiota for improved glycaemic control? Pract Diab 2020;37:133-7. [DOI: 10.1002/pdi.2285] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Kumar D, Behal S, Bhattacharyya R, Banerjee D. Pseudoesterase activity of albumin: A probable determinant of cholesterol biosynthesis. Med Hypotheses 2018;115:42-5. [PMID: 29685194 DOI: 10.1016/j.mehy.2018.03.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Tseng CH. Metformin Use and Leukemia Risk in Patients With Type 2 Diabetes Mellitus. Front Endocrinol (Lausanne) 2020;11:541090. [PMID: 33193076 DOI: 10.3389/fendo.2020.541090] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Anfinogenova Y, Grakova EV, Shvedova M, Kopieva KV, Teplyakov AT, Popov SV. Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure. Heart Fail Rev 2018;23:481-97. [PMID: 28849410 DOI: 10.1007/s10741-017-9647-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
6 Tseng CH. Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus. Biomolecules 2021;11:1226. [PMID: 34439890 DOI: 10.3390/biom11081226] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tseng CH. Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus. J Crohns Colitis 2021;15:64-73. [PMID: 32604412 DOI: 10.1093/ecco-jcc/jjaa136] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
8 Zhang Q, Xiao X, Li M, Yu M, Ping F, Zheng J, Wang T, Wang X. Vildagliptin increases butyrate-producing bacteria in the gut of diabetic rats. PLoS One. 2017;12:e0184735. [PMID: 29036231 DOI: 10.1371/journal.pone.0184735] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
9 Tseng CH. Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis. J Am Heart Assoc 2019;8:e011640. [PMID: 31630591 DOI: 10.1161/JAHA.118.011640] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 5.7] [Reference Citation Analysis]
10 Tseng CH. The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature. Biomolecules 2021;11:1022. [PMID: 34356646 DOI: 10.3390/biom11071022] [Reference Citation Analysis]
11 Kramer P. Mitochondria-Microbiota Interaction in Neurodegeneration. Front Aging Neurosci 2021;13:776936. [PMID: 35002678 DOI: 10.3389/fnagi.2021.776936] [Reference Citation Analysis]
12 Tseng CH. Chronic Metformin Therapy is Associated with a Lower Risk of Hemorrhoid in Patients with Type 2 Diabetes Mellitus. Front Pharmacol 2020;11:578831. [PMID: 33664665 DOI: 10.3389/fphar.2020.578831] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
13 Cheng D, Xu Q, Wang Y, Li G, Sun W, Ma D, Zhou S, Liu Y, Han L, Ni C. Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling. J Transl Med 2021;19:349. [PMID: 34399790 DOI: 10.1186/s12967-021-03036-5] [Reference Citation Analysis]
14 Rafaqat S, Rafaqat S, Rafaqat S. Pathophysiological aspects of insulin resistance in Atrial Fibrillation: novel therapeutic approaches. Int J Arrhythm 2022;23. [DOI: 10.1186/s42444-021-00057-5] [Reference Citation Analysis]
15 Zhao Y, Wang Z. Gut microbiome and cardiovascular disease. Curr Opin Cardiol 2020;35:207-18. [PMID: 32068612 DOI: 10.1097/HCO.0000000000000720] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
16 Adak T, Samadi A, Ünal AZ, Sabuncuoğlu S. A reappraisal on metformin. Regulatory Toxicology and Pharmacology 2018;92:324-32. [DOI: 10.1016/j.yrtph.2017.12.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
17 Maniar K, Singh V, Moideen A, Bhattacharyya R, Chakrabarti A, Banerjee D. Inhalational supplementation of metformin butyrate: A strategy for prevention and cure of various pulmonary disorders. Biomed Pharmacother 2018;107:495-506. [PMID: 30114633 DOI: 10.1016/j.biopha.2018.08.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Zhang Q, Xiao X, Zheng J, Li M, Yu M, Ping F, Wang T, Wang X. Featured article: Structure moderation of gut microbiota in liraglutide-treated diabetic male rats. Exp Biol Med (Maywood) 2018;243:34-44. [PMID: 29171288 DOI: 10.1177/1535370217743765] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
19 Kaur S, Bhattacharyya R, Banerjee D. Hydrochlorothiazide and Indapamide bind the NADPH binding site of bacterial Dihydrofolate Reductase: results of an in-silico study and their implications. In Silico Pharmacol 2020;8:5. [PMID: 33214986 DOI: 10.1007/s40203-020-00056-9] [Reference Citation Analysis]
20 Bonea M, Filip GA, Toma VA, Baldea I, Berghian AS, Decea N, Olteanu D, Moldovan R, Crivii C, Vinași RC, Micluția IV. The Modulatory Effect of Metformin on Ethanol-Induced Anxiety, Redox Imbalance, and Extracellular Matrix Levels in the Brains of Wistar Rats. J Mol Neurosci 2020;70:1943-61. [PMID: 32621100 DOI: 10.1007/s12031-020-01593-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Tseng CH. Metformin Reduces the Risk of Diverticula of Intestine in Taiwanese Patients with Type 2 Diabetes Mellitus. Front Pharmacol 2021;12:739141. [PMID: 34557103 DOI: 10.3389/fphar.2021.739141] [Reference Citation Analysis]
22 Tseng CH. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus. Sci Rep 2021;11:12400. [PMID: 34117321 DOI: 10.1038/s41598-021-91902-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Su Y, Chen Q, Ju Y, Li W, Li W. Palmitate induces human glomerular mesangial cells fibrosis through CD36-mediated transient receptor potential canonical channel 6/nuclear factor of activated T cell 2 activation. Biochim Biophys Acta Mol Cell Biol Lipids 2020;1865:158793. [PMID: 32800850 DOI: 10.1016/j.bbalip.2020.158793] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Almugadam BS, Liu Y, Chen SM, Wang CH, Shao CY, Ren BW, Tang L. Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents. J Diabetes Res 2020;2020:7253978. [PMID: 33062716 DOI: 10.1155/2020/7253978] [Reference Citation Analysis]
25 Tseng CH. Metformin Use Is Associated With a Lower Incidence of Hospitalization for Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus. Front Med (Lausanne) 2020;7:592901. [PMID: 33693008 DOI: 10.3389/fmed.2020.592901] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
26 Kumar NP, Moideen K, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Hissar S, Kornfeld H, Babu S. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy. BMC Infect Dis. 2019;19:1039. [PMID: 31818258 DOI: 10.1186/s12879-019-4648-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Tseng CH. Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients. J Clin Med 2018;7:E264. [PMID: 30205606 DOI: 10.3390/jcm7090264] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
28 Tseng CH. Metformin reduces risk of varicose veins in patients with type 2 diabetes. Diabetes Metab Res Rev 2020;36:e3206. [PMID: 31322821 DOI: 10.1002/dmrr.3206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
29 Yen F, Wei JC, Shih Y, Pan W, Hsu C, Hwu C. Role of Metformin in Morbidity and Mortality Associated with Urinary Tract Infections in Patients with Type 2 Diabetes. JPM 2022;12:702. [DOI: 10.3390/jpm12050702] [Reference Citation Analysis]
30 Chen J, Zhao KN, Vitetta L. Effects of Intestinal Microbial⁻Elaborated Butyrate on Oncogenic Signaling Pathways. Nutrients 2019;11:E1026. [PMID: 31067776 DOI: 10.3390/nu11051026] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]
31 Zhao Y, Wang Z, Mao Y, Li B, Zhu Y, Zhang S, Wang S, Jiang Y, Xu N, Xie Y, Xie W, Zhang Y. NEAT1 regulates microtubule stabilization via FZD3/GSK3β/P-tau pathway in SH-SY5Y cells and APP/PS1 mice. Aging (Albany NY) 2020;12:23233-50. [PMID: 33221742 DOI: 10.18632/aging.104098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
32 Maniar K, Singh V, Chakrabarti A, Bhattacharyya R, Banerjee D. High dose targeted delivery on cancer sites and the importance of short-chain fatty acids for metformin's action: Two crucial aspects of the wonder drug. Regul Toxicol Pharmacol 2018;97:15-6. [PMID: 29857113 DOI: 10.1016/j.yrtph.2018.05.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Zhao J, Zhang QL, Shen JH, Wang K, Liu J. Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy. Acta Pharmacol Sin 2019;40:507-13. [PMID: 29941869 DOI: 10.1038/s41401-018-0029-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]